Exome Asset Management LLC

Position in CYTK — Cytokinetics Inc

CIK 2011932 NEW YORK, NY

Position in CYTK

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,836,053

-$1,090,498 QoQ

Shares Held

103,718

-16.9% QoQ

Ownership

0.083%

of shares outstanding

% of Portfolio

4.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Exome Asset Management LLC holds $121,183,293 across 31 Biotechnology names. CYTK ranks #5 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	45,469	$14,649,657
2	COGT	Cogent Biosciences, Inc.	278,533	$10,720,735
3	ELVN	Enliven Therapeutics, Inc.	220,091	$8,627,567
4	IONS	Ionis Pharmaceuticals Inc	110,064	$8,264,705
5	CYTK	Cytokinetics Inc This page	103,718	$6,836,053
6	ALMS	Alumis Inc.	279,176	$6,150,247
7	BBIO	BridgeBio Pharma, Inc.	67,492	$5,011,955
8	VERA	Vera Therapeutics, Inc.	114,991	$4,626,087

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,836,053	103,718	-16.9%	Shares	Sole	2026-05-15
2025-12-31	$7,926,551	124,749	-12.4%	Shares	Sole	2026-02-13
2025-09-30	$7,827,238	142,417	+23.0%	Shares	Sole	2025-11-14
2025-06-30	$3,826,593	115,817	+11.9%	Shares	Sole	2025-08-15
2025-03-31	$4,158,981	103,483	+57.1%	Shares	Sole	2025-05-16
2024-12-31	$3,099,136	65,883	+12.5%	Shares	Sole	2025-02-14
2024-09-30	$3,093,182	58,583	+125.2%	Shares	Sole	2024-11-14
2024-03-31	$1,823,420	26,008	-25.5%	Shares	Sole	2024-05-15
2023-12-31	$2,914,468	34,908	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.